Original articleInsulin-like growth factors I and II in evaluation of growth retardation*
References (27)
- et al.
The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin
J Biol Chem
(1978) - et al.
Primary structure of human insulin-like growth factor II
FEBS Lett
(1978) - et al.
Purification and primary structure of a polypeptide with multiplication-stimulating activity from rat liver cell cultures: homology with human insulin-like growth factor II
J Biol Chem
(1981) - et al.
Somatomedin-C and the assessment of growth
Pediatr Clin North Am
(1980) - et al.
Relationship of somatomedin-C concentrations to pubertal changes
J Pediatr
(1983) - et al.
The use of a commercially available somatomedin-C radioimmunoassay in patients with disorders of growth
J Pediatr
(1981) - et al.
Differences in somatomedin-C between short-normal subjects and those of normal height
J Pediatr
(1985) - et al.
Prospective clinical trial of human growth hormone in short children without growth hormone deficiency
J Pediatr
(1984) - et al.
Biosynthetic methionyl-human growth hormone is biologically active in adult humans
Lancet
(1982) - et al.
The somatomedins: a family of insulin-like hormones under growth hormone control
Rec Prog Horm Res
(1974)
Sequence analysis of somatomedin-C: confirmation of identity with insulin-like growth factor I
Endocrinology
(1983)
Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia
J Clin Invest
(1981)
A review of growth hormone stimulation tests in children
Pediatrics
(1974)
Cited by (239)
Disorders of Childhood Growth
2020, Sperling Pediatric Endocrinology: Expert Consult - Online and PrintNormal and Aberrant Growth in Children
2015, Williams Textbook of EndocrinologyDisorders of growth hormone/insulin-like growth factor secretion and action
2014, Pediatric Endocrinology: Fourth EditionReference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents
2012, Clinical BiochemistryCitation Excerpt :All three subunits are positively regulated by growth hormone in vivo, and their levels in the circulation are directly correlated with body growth [6]. The clinical use of IGF-I and IGFBP-3 measurements has primarily been for diagnosing or excluding growth hormone (GH) deficiency and for monitoring GH therapy [7–10]. The proper means for establishing a diagnosis of GH deficiency continues to be highly controversial.
Normal and Aberrant Growth
2011, Williams Textbook of Endocrinology, Twelfth Edition
- *
Supported in part by Research Grants AM28229 (R.G.R.) and AM 24085 (R.L.H.) from the National Institutes of Health. Dr. Lee is a recipient of a fellowship award from the Juvenile Diabetes Foundation. Dr. Rosenfeld is the recipient of a Research Career Development Award from the National Institutes of Health.
Copyright © 1986 Published by Mosby, Inc.